Company / Operating Income per Share
ENANTA PHARMACEUTICALS INC Operating Income per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$6.47
FY2025
5-year range
-$6.47 / $1.83
FY2021-FY2025
Trend
-10.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Income per Share has declined for 5 consecutive years, from $4.48 in FY2020 to $-6.47 in FY2025.
Based on SEC 10-K filings.
-6.47 in FY2025.
Declined from $-5.27 to $-6.47 over the past 2 years.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- ENANTA PHARMACEUTICALS INC's operating income per share has declined for 5 consecutive years.
- In FY2025, operating income per share decreased 10.1% year-over-year.
- Peak operating income per share was recorded in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.48 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$6.47 | -10.1% |
| FY2024 | -$5.88 | -11.6% |
| FY2023 | -$5.27 | -156.2% |
| FY2022 | -$2.06 | -212.4% |
| FY2021 | $1.83 | -59.2% |
| FY2020 | $4.48 | +253.2% |
| FY2019 | $1.27 | -21.3% |
| FY2018 | $1.61 | -75.3% |
| FY2017 | $6.52 | +543.0% |
| FY2016 | $1.01 | +108.9% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026